Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit

Article Spanish OPEN
Villena, Rodolfo; González, Claudio A; Nalegach, M. Elisa; Vásquez, Alexandra; Villareal, Marcela; Drago, Michele;
(2014)
  • Publisher: Sociedad Chilena de Infectología
  • Subject: Vancomicina | paciente crítico | children | farmacocinética | criticall illness | pharmacokinetics | Vancomycin | niños

Introducción: Los pacientes críticos pediátricos presentan alteraciones en la distribución y eliminación de vancomicina, lo que hace necesaria su monitorización terapéutica; sin embargo, los rangos basales óptimos no han sido validados en niños. Objetivo: Describir el m... View more
  • References (26)
    26 references, page 1 of 3

    1.- Jones R N. Microbiological features of vancomycin in the 21st Century: minimum inhibitory concentration creep, bactericidal/ static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006; 42 Suppl 1: S13-24.

    2.- Marsot A, Boulamery A, Bruguerolle B, Simon N. Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet. 2012; 51 (1): 1-13.

    3.- Cunha B A. Vancomycin. Med Clin North Am 1995; 79 (4): 817-31.

    4.- Lodise T P, Patel N, Lomaestro B M, Rodvold K A, Drusano G L. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009; 49 (4): 507-14.

    5.- Fridkin S K, Edwards J R, Pichette S C, Pryor E R, McGowan J E Jr, Tenover F C, et al. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999; 28 (5): 1119-25.

    6.- Roberts J A, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37 (3): 840-51.

    7.- Rodvold K A, Everett J A, Pryka R D, Kraus D M. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin Pharmacokinet 1997; 33 (1): 32-51.

    8.- Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66 (1): 82-98.

    9.- Giachetto G A, Telechea H M, Speranza N, Oyarzún M, Nanni L, Menchaca A. Vancomycin pharmacokinetic-pharmacodynamic parameters to optimize dosage administration in critically ill children. Pediatr Crit Care Med 2011; 12 (6): e250-4.

    10.- Liu C, Bayer A, Cosgrove S E, Daum R S, Fridkin S K, Gorwitz R J, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52 (3): 285-92.

  • Similar Research Results (4)
  • Metrics
Share - Bookmark